Masterclasses

Day B: Bipolar / Perinatal / ADHD

Declarations of Interests

Professor Hamish McAllister-Williams

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. Janssen, LivaNova, Lundbeck, P1Vital, Sage Therapeutics, Syntropharma

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. Eli Lilly

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. Janssen, LivaNova, Lundbeck, Magstim, OM Pharma, Pfizer, Sunovion, Wiley

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. COMPASS Pathways: trial of psilocybin for depression, LivaNova

  21. If there is anything else you feel it necessary to disclose, please provide details below:

Form completed on 24th July 2020

Dr Richard McQuade

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. No

Form completed on 3rd September 2020

Professor Nicol Ferrier

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. No

Form completed on 30th August 2020

Professor Ian Jones

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. 2018-2022 Takeda £3,982,340. Identify new potential targets for therapeutic intervention in schizophrenia

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. No

Form completed on 6th January 2020

Dr Angelika Wieck

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. no

Form completed on 21st January 2020

Professor Kevin Fone

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. Heptares Ltd, UK, Roche, Basel, Switzerland

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:

Form completed on 5th August 2019

Professor Allan Young

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. Johnson & Johnson & Livanova

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. Acted as an expert witness to GSK

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. Janssen, Compass, Livanova

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. Paid lectures and advisory boards for the following companies with drugs used in affective and related disorders Astrazenaca, Eli Lilly, Janssen, Lundbeck, Sunovion, Servier, Livanova, Sage, Sandoz

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. Janssen, COMPASS, Livanova

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. Employed by King’s College London; Honorary Consultant SLaM (NHS UK) Paid lectures and advisory boards for the following companies with drugs used in affective and related disorders Astrazenaca, Eli Lilly, Janssen, Lundbeck, Sunovion, Servier, Livanova, COMPASS, Sage No share holdings in pharmaceutical companies Lead Investigator for Embolden Study (AZ), BCI Neuroplasticity study and Aripiprazole Mania Study Investigator initiated studies from AZ, Eli Lilly, Lundbeck, Wyeth Grant funding (past and present): NIMH (USA); CIHR (Canada); NARSAD (USA); Stanley Medical Research Institute (USA); MRC (UK); Wellcome Trust (UK); Royal College of Physicians (Edin); BMA (UK); UBC-VGH Foundation (Canada); WEDC (Canada); CCS Depression Research Fund (Canada); MSFHR (Canada); NIHR (UK). Janssen (UK)

Form completed on 23rd July 2020

Dr James Kustow

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No

  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. Since I graduated from medical school I have had a small number of Astra Zeneca shares (47)

  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No

  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. I provided Consultancy services to Eli Lilly in 2015 I received Consultancy fees from Shire in 2015 I am a member of UKAAN’s Executive board and chair UKAAN’s Training committee

  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No

  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No

  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No

  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. I received speaker fees from Shire in 2015

  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. I was invited to the European Psychiatric Association conference in Madrid in 2016

  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No

  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. I have a private practice in the Nightingale hospital in London

Form completed on 28th January 2017